In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vaccines company China NT Pharma closes HKD1.07bn IPO on HKSE

Executive Summary

China NT Pharma Group Co. Ltd. (vaccines distributor) has netted HKD1.07bn ($137.6mm). in a global initial public offering of 270.5mm new shares at HKD$4.54, the low end of its anticipated HKD4.54-6.00 range. Included in the offering are 35.7mm Hong Kong shares and 234.8mm International Placing shares.
Deal Industry
  • Distributors
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies